>
>
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, June 20, 2022 /PRNewswire/ – SQI Diagnostics Inc. (“SQI” or the
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA/ TORONTO, June 17, 2022 /PRNewswire/ – SQI Diagnostics Inc.
New Business Contributes $5.5M in Revenue TORONTO, May 26, 2022 /PRNewswire/ – SQI Diagnostics Inc. (TSXV: SQD) (OTCQB: SQIDF), a leader in the science of
TORONTO, March 25, 2022 /PRNewswire/ – SQI Diagnostics Inc. (TSXV: SQD) (OTCQB: SQIDF), a leader in the science of lung health that develops and manufactures
— Conditional Approval Makes Quick, Precise Test for Presence of Antibodies to SARS-CoV-2 Available in the US — TORONTO, March 3, 2022 /PRNewswire/ – SQI
TORONTO, Feb. 28, 2022 /PRNewswire/ – SQI Diagnostics Inc. (TSXV: SQD) (OTCQB: SQIDF), a leader in the science of lung health that develops and manufactures
TORONTO, Jan. 26, 2022 /PRNewswire/ – SQI Diagnostics Inc. (‘SQI” or the “Company“) (TSXV: SQD) (OTCQB: SQIDF), a leader in the science of lung health that develops
Companies Plan to Commercialize Breath-Based Detection of Lung Infection and Transplant Rejection TORONTO, Jan. 24, 2022 /PRNewswire/ – SQI Diagnostics Inc. (“SQI” or the “Company”) (TSXV:
The New Frontiers in Research Fund – Transformation Award Will Support World-Leading Innovation in Organ Transplant. TORONTO, Jan. 13, 2022 /PRNewswire/ – SQI Diagnostics Inc.
TORONTO, Oct. 19, 2021 /PRNewswire/ – SQI Diagnostics Inc. (“SQI” or the “Company”) (TSXV: SQD) (OTCQB: SQIDF), a life sciences and diagnostics company that develops
